AMA Ed Hub Logo

Learn more on prescription drugs from AMA Ed Hub™
Red JAMA Logo

Learn more on prescription drugs from JAMA Network™
2025 Annual Meeting of the HOD

Learn more on prescription drugs from PolicyFinder
United States Adopted Names Council

United States Adopted Names (USAN)
Clear Search
·
3 Min Read

How AMA has advocated for Sunshine Act implementation overhaul

As the Centers for Medicare & Medicaid Services (CMS) rolls out the online database of physicians’ financial interactions with manufacturers of drugs and medical devices, troubling questions remain about the accuracy of the data and the lack of context with which it is being presented.

Medicare & Medicaid
Copy
·
4 Min Read

6 things you need to know about hydrocodone reclassification

The Drug Enforcement Administration reclassified hydrocodone combination products as Schedule II controlled substances. You need to know these 6 six key points about major changes to prescribing practices.

Behavioral Health
Copy
·
3 Min Read

Time running out to review Sunshine data—and it isn't very accurate

Less than two weeks remain for physicians to review and dispute data about their financial interactions with medical device and drug manufacturers before the information goes public Sept. 30.

Medicare & Medicaid
Copy
·
2 Min Read

Troubles with Sunshine Act website? We're taking them to CMS

As the federal website through which physicians can review their Sunshine Act financial data continues to experience technical problems, you can share your experience using the site in a brief survey, open through Monday.

Medicare & Medicaid
Copy
·
3 Min Read

Physicians ask CMS to postpone Sunshine Act data release

The Physician Payments Sunshine Act roll-out is suffering from a major lack of communication, a shortened timeline and a confusing registration process, the AMA and 112 specialty and state medical societies told the Centers for Medicare & Medicaid Services in a letter.

Medicare & Medicaid
Copy
·
4 Min Read

How to dispute incorrect financial data before it goes public

Physicians can review reports about their financial interactions with manufacturers of drugs and medical devices now through Aug. 27 under the Physician Payments Sunshine Act (also known as the Open Payments program).

Medicare & Medicaid
Copy
·
2 Min Read

Physicians should know about their personal data, AMA tells CMS

Personally identified data about physicians not publicly available soon could be shared with government agencies, law enforcement and Medicare contractors without physicians’ knowledge, under a new “system of records” announced by the Centers for Medicare & Medicaid Services (CMS).

Medicare & Medicaid
Copy
·
3 Min Read

Sunshine Act proposal threatens doctors' due process for disputes

A newly proposed dispute resolution process for inaccurate Physician Payments Sunshine Act data would deny physicians their due process rights, the AMA told the Centers for Medicare & Medicaid Services in a comment letter last week that calls for fairness and urges the agency to modify the deadline for publication of physicians’ payment data.

Medicare & Medicaid
Copy
·
3 Min Read

Extend review timeline for Sunshine Act, AMA tells CMS

Physicians won’t have enough time to review and challenge false or inaccurate data about financial interactions they have had with drug and medical device companies as a result of delays by the Centers for Medicare & Medicaid Services in implementing the Physician Payments Sunshine Act, the AMA told the agency.

Medicare & Medicaid
Copy